NEXAF Detraining presented at the ESC Preventive Cardiology congress

The NEXAF Detraining study was recently presented during the ESC Preventive Cardiology congress in Malaga, Spain. During his talk ‘Atrial fibrillation – the achilles heel of the middle-aged athlete’, Marius Myrstad, who is the primary investigator of the study, took the opportunity to present the background and design of the study. The NEXAF Detraining study is the first randomized controlled study of atrial fibrillation in endurance athletes, and aims to investigate whether a period of training adaption can reduce the burden of atrial fibrillation.

The study protocol of the NEXAF Detraining study was recently published in the BMJ Open Sport&Exercise Medicine.